Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Didier Raoult and Jean-Christophe Lagier.
Connection Strength

27.421
  1. High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report. Int J Infect Dis. 2021 Jul; 108:1-3.
    View in: PubMed
    Score: 0.938
  2. Bouillabaisse or Fish Soup: The Limitations of Meta-analysis Confronted to the Inconsistency of Fecal Microbiota Transplantation Studies. Clin Infect Dis. 2020 05 23; 70(11):2454.
    View in: PubMed
    Score: 0.883
  3. Culturomics provides critical prokaryote strains for anti-Listeria and anti-cancer probiotics. Int J Antimicrob Agents. 2019 Oct; 54(4):407-409.
    View in: PubMed
    Score: 0.826
  4. Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them. Curr Opin Infect Dis. 2018 12; 31(6):463-470.
    View in: PubMed
    Score: 0.798
  5. Naming microorganisms: the contribution of the IHU Méditerranée Infection, Marseille, France. New Microbes New Infect. 2018 Nov; 26:S89-S95.
    View in: PubMed
    Score: 0.781
  6. Culturing the human microbiota and culturomics. Nat Rev Microbiol. 2018 05 01; 16:540-550.
    View in: PubMed
    Score: 0.766
  7. Koch Postulate: Why Should we Grow Bacteria? Arch Med Res. 2017 11; 48(8):774-779.
    View in: PubMed
    Score: 0.758
  8. Many More Microbes in Humans: Enlarging the Microbiome Repertoire. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S20-S29.
    View in: PubMed
    Score: 0.729
  9. Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage. Future Microbiol. 2017 06; 12:609-620.
    View in: PubMed
    Score: 0.720
  10. Acute infections caused by Tropheryma whipplei. Future Microbiol. 2017 03; 12:247-254.
    View in: PubMed
    Score: 0.706
  11. Motorcycles, Cell Phones, and Electricity Can Dramatically Change the Epidemiology of Infectious Disease in Africa. Am J Trop Med Hyg. 2017 May; 96(5):1009-1010.
    View in: PubMed
    Score: 0.702
  12. [Culturomics: a method to study human gut microbiota]. Med Sci (Paris). 2016 Nov; 32(11):923-925.
    View in: PubMed
    Score: 0.697
  13. [Fecal microbiota transplantation: indications and perspectives]. Med Sci (Paris). 2016 Nov; 32(11):991-997.
    View in: PubMed
    Score: 0.697
  14. Critical Microbiological View of SER-109. J Infect Dis. 2017 01 01; 215(1):161-162.
    View in: PubMed
    Score: 0.689
  15. Efficacy of antibiotic therapy in polyarthritis: a clue suggesting Whipple's disease. Int J Antimicrob Agents. 2009 Oct; 34(4):389-90.
    View in: PubMed
    Score: 0.416
  16. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants. J Clin Med. 2021 Jul 24; 10(15).
    View in: PubMed
    Score: 0.240
  17. Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States. Clin Infect Dis. 2021 06 01; 72(11):e928.
    View in: PubMed
    Score: 0.237
  18. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage. Clin Microbiol Infect. 2021 Sep; 27(9):1352.e1-1352.e5.
    View in: PubMed
    Score: 0.236
  19. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant. Int J Infect Dis. 2021 May; 106:228-236.
    View in: PubMed
    Score: 0.234
  20. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.234
  21. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne). 2021; 8:640073.
    View in: PubMed
    Score: 0.233
  22. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000.
    View in: PubMed
    Score: 0.232
  23. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
    View in: PubMed
    Score: 0.232
  24. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243.
    View in: PubMed
    Score: 0.230
  25. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244.
    View in: PubMed
    Score: 0.230
  26. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236.
    View in: PubMed
    Score: 0.230
  27. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237.
    View in: PubMed
    Score: 0.230
  28. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235.
    View in: PubMed
    Score: 0.230
  29. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239.
    View in: PubMed
    Score: 0.230
  30. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238.
    View in: PubMed
    Score: 0.230
  31. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241.
    View in: PubMed
    Score: 0.230
  32. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242.
    View in: PubMed
    Score: 0.230
  33. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.230
  34. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis. 2021 Jan-Feb; 39:101954.
    View in: PubMed
    Score: 0.230
  35. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2021 04; 82(4):84-123.
    View in: PubMed
    Score: 0.228
  36. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238.
    View in: PubMed
    Score: 0.228
  37. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19.
    View in: PubMed
    Score: 0.227
  38. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clin Microbiol Infect. 2021 01; 27(1):132-133.
    View in: PubMed
    Score: 0.226
  39. Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125.
    View in: PubMed
    Score: 0.226
  40. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.225
  41. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.222
  42. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
    View in: PubMed
    Score: 0.221
  43. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759.
    View in: PubMed
    Score: 0.221
  44. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156.
    View in: PubMed
    Score: 0.220
  45. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.220
  46. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.219
  47. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603.
    View in: PubMed
    Score: 0.219
  48. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.218
  49. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.218
  50. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
    View in: PubMed
    Score: 0.218
  51. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
    View in: PubMed
    Score: 0.216
  52. Brachybacterium massiliense sp. nov., a new bacterium isolated from stool from a healthy Senegalese child. New Microbes New Infect. 2019 Sep; 31:100588.
    View in: PubMed
    Score: 0.208
  53. Arcanobacterium ihumii sp. nov., Varibaculum vaginae sp. nov. and Tessaracoccus timonensis sp. nov., isolated from vaginal swabs from healthy Senegalese women. New Microbes New Infect. 2019 Sep; 31:100585.
    View in: PubMed
    Score: 0.208
  54. Corynebacterium senegalense sp. nov. and Arthrobacter senegalensis sp. nov., two new Actinobacteria isolated from skin swab from the palm of hand. New Microbes New Infect. 2019 Sep; 31:100583.
    View in: PubMed
    Score: 0.207
  55. Failure of metagenomics in detecting emerging pathogens, the Clostridium difficile paradigm. J Infect. 2019 05; 78(5):409-421.
    View in: PubMed
    Score: 0.203
  56. Bacterial Cocktail to Treat Clostridium difficile Infection: Primum Non Nocere. Clin Infect Dis. 2018 11 13; 67(11):1799.
    View in: PubMed
    Score: 0.199
  57. Repertoire of the gut microbiota from stomach to colon using culturomics and next-generation sequencing. BMC Microbiol. 2018 10 24; 18(1):157.
    View in: PubMed
    Score: 0.198
  58. From Culturomics to Clinical Microbiology and Forward. Emerg Infect Dis. 2018 09; 24(9):1683-1690.
    View in: PubMed
    Score: 0.196
  59. Anaerococcus jeddahensis sp. nov., a New Bacterial Species Isolated From Healthy Nomadic Bedouin Woman From Saudi Arabia. Curr Microbiol. 2018 Nov; 75(11):1419-1428.
    View in: PubMed
    Score: 0.194
  60. Noncontiguous finished genome sequences and description of Bacteroides mediterraneensis sp. nov., Bacteroides ihuae sp. nov., Bacteroides togonis sp. nov., Bacteroides ndongoniae sp. nov., Bacteroides ilei sp. nov. and Bacteroides congonensis sp. nov. identified by culturomics. New Microbes New Infect. 2018 Nov; 26:73-88.
    View in: PubMed
    Score: 0.193
  61. The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species. Microbiome. 2018 05 24; 6(1):94.
    View in: PubMed
    Score: 0.192
  62. Halophilic & halotolerant prokaryotes in humans. Future Microbiol. 2018 06 01; 13:799-812.
    View in: PubMed
    Score: 0.192
  63. Clostridium scindens Is Present in the Gut Microbiota during Clostridium difficile Infection: a Metagenomic and Culturomic Analysis. J Clin Microbiol. 2018 05; 56(5).
    View in: PubMed
    Score: 0.191
  64. Metagenomics, culturomics, and the human gut microbiota. Expert Rev Anti Infect Ther. 2018 05; 16(5):373-375.
    View in: PubMed
    Score: 0.191
  65. Genome sequence and description of Haloferax massiliense sp. nov., a new halophilic archaeon isolated from the human gut. Extremophiles. 2018 May; 22(3):485-498.
    View in: PubMed
    Score: 0.189
  66. 'Cellulomonas timonensis' sp. nov., taxonogenomics description of a new bacterial species isolated from human gut. New Microbes New Infect. 2018 May; 23:7-16.
    View in: PubMed
    Score: 0.188
  67. Sediminibacillus massiliensis sp. nov., a moderately halophilic, Gram-positive bacterium isolated from a stool sample of a young Senegalese man. Antonie Van Leeuwenhoek. 2018 Jul; 111(7):1225-1236.
    View in: PubMed
    Score: 0.188
  68. How mass spectrometric approaches applied to bacterial identification have revolutionized the study of human gut microbiota. Expert Rev Proteomics. 2018 03; 15(3):217-229.
    View in: PubMed
    Score: 0.188
  69. 'Gracilibacillus phocaeensis' sp. nov., 'Sediminibacillus massiliensis' sp. nov. and 'Virgibacillus ndiopensis' sp. nov., three halophilic species isolated from salty human stools by culturomics. New Microbes New Infect. 2017 Nov; 20:51-54.
    View in: PubMed
    Score: 0.183
  70. From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
    View in: PubMed
    Score: 0.182
  71. Description of 'Blautia phocaeensis' sp. nov. and 'Lachnoclostridium edouardi' sp. nov., isolated from healthy fresh stools of Saudi Arabia Bedouins by culturomics. New Microbes New Infect. 2017 Sep; 19:129-131.
    View in: PubMed
    Score: 0.180
  72. Description of 'Arabia massiliensis' gen. nov., sp. nov., 'Gordonibacter massiliensis' sp. nov., and 'Bacilliculturomica massiliensis' gen. nov., sp. nov., isolated from a faecal specimen of a 50-year-old Saudi Bedouin woman. New Microbes New Infect. 2017 Sep; 19:87-90.
    View in: PubMed
    Score: 0.180
  73. Gut Bacteria Missing in Severe Acute Malnutrition, Can We Identify Potential Probiotics by Culturomics? Front Microbiol. 2017; 8:899.
    View in: PubMed
    Score: 0.179
  74. Description of 'Beduinibacterium massiliense' gen. nov., sp. nov., 'Massilimaliae massiliensis' gen. nov., sp. nov., 'Provencibacterium massiliense' gen. nov., sp. nov. and 'Oscilibacter massiliensis' sp. nov., isolated from a faecal specimen of a 19-year-old healthy Saudi Arabian Bedouin by culturomics. New Microbes New Infect. 2017 Sep; 19:78-82.
    View in: PubMed
    Score: 0.179
  75. 'Khelaifiella massiliensis', 'Niameybacter massiliensis', 'Brachybacterium massiliense', 'Enterobacter timonensis', 'Massilibacillus massiliensis', new bacterial species and genera isolated from the gut microbiota of healthy infants. New Microbes New Infect. 2017 Sep; 19:1-7.
    View in: PubMed
    Score: 0.178
  76. 'Collinsella phocaeensis' sp. nov., 'Clostridium merdae' sp. nov., 'Sutterella massiliensis' sp. nov., 'Sutturella timonensis' sp. nov., 'Enorma phocaeensis' sp. nov., 'Mailhella massiliensis' gen. nov., sp. nov., 'Mordavella massiliensis' gen. nov., sp. nov. and 'Massiliprevotella massiliensis' gen. nov., sp. nov., 9 new species isolated from fresh stool samples of healthy French patients. New Microbes New Infect. 2017 May; 17:89-95.
    View in: PubMed
    Score: 0.177
  77. 'Actinomyces provencensis' sp. nov., 'Corynebacterium bouchesdurhonense' sp. nov., 'Corynebacterium provencense' sp. nov. and 'Xanthomonas massiliensis' sp. nov., 4 new species isolated from fresh stools of obese French patients. New Microbes New Infect. 2017 Jul; 18:24-27.
    View in: PubMed
    Score: 0.176
  78. Description of 'Bacillus dakarensis' sp. nov., 'Bacillus sinesaloumensis' sp. nov., 'Gracilibacillus timonensis' sp. nov., 'Halobacillus massiliensis' sp. nov., 'Lentibacillus massiliensis' sp. nov., 'Oceanobacillus senegalensis' sp. nov., 'Oceanobacillus timonensis' sp. nov., 'Virgibacillus dakarensis' sp. nov. and 'Virgibacillus marseillensis' sp. nov., nine halophilic new species isolated from human stool. New Microbes New Infect. 2017 May; 17:45-51.
    View in: PubMed
    Score: 0.176
  79. Massilioclostridium coli gen. nov., sp. nov., a new member of the Clostridiaceae family isolated from the left colon of a 27-year-old woman. New Microbes New Infect. 2017 Mar; 16:63-72.
    View in: PubMed
    Score: 0.175
  80. 'Traorella massiliensis' gen. nov., sp. nov., a new bacterial species isolated from the left colon of a 76-year-old woman. New Microbes New Infect. 2017 May; 17:13-14.
    View in: PubMed
    Score: 0.174
  81. 'Tidjanibacter massiliensis' gen. nov., sp. nov., a new bacterial species isolated from human colon. New Microbes New Infect. 2017 May; 17:21-22.
    View in: PubMed
    Score: 0.174
  82. 'Ileibacterium massiliense' gen. nov., sp. nov., a new bacterial species isolated from human ileum of a patient with Crohn disease. New Microbes New Infect. 2017 May; 17:25-26.
    View in: PubMed
    Score: 0.173
  83. 'Duodenibacillus massiliensis' gen. nov., sp. nov., a new species identified in human duodenum. New Microbes New Infect. 2017 May; 17:43-44.
    View in: PubMed
    Score: 0.173
  84. 'Merdibacter massiliensis' gen. nov., sp. nov., isolated from human ileum. New Microbes New Infect. 2017 Jan; 15:89-91.
    View in: PubMed
    Score: 0.173
  85. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  86. Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening. J Clin Med. 2021 Jun 16; 10(12).
    View in: PubMed
    Score: 0.059
  87. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med. 2021 Jun 15; 10(12).
    View in: PubMed
    Score: 0.059
  88. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
    View in: PubMed
    Score: 0.059
  89. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
    View in: PubMed
    Score: 0.059
  90. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.059
  91. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21.
    View in: PubMed
    Score: 0.058
  92. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun; 27(6):931-932.
    View in: PubMed
    Score: 0.058
  93. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881.
    View in: PubMed
    Score: 0.057
  94. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117.
    View in: PubMed
    Score: 0.057
  95. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
    View in: PubMed
    Score: 0.057
  96. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407.
    View in: PubMed
    Score: 0.057
  97. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
    View in: PubMed
    Score: 0.056
  98. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020 Jul; 27(5):275-276.
    View in: PubMed
    Score: 0.055
  99. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.055
  100. Among Live and Dead Bacteria, the Optimization of Sample Collection and Processing Remains Essential in Recovering Gut Microbiota Components. Front Microbiol. 2019; 10:1606.
    View in: PubMed
    Score: 0.052
  101. Lysinibacillus timonensis sp. nov., Microbacterium timonense sp. nov., and Erwinia mediterraneensis sp. nov., three new species isolated from the human skin. New Microbes New Infect. 2019 Sep; 31:100579.
    View in: PubMed
    Score: 0.052
  102. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol. 2019 05; 14:623-641.
    View in: PubMed
    Score: 0.051
  103. Description and genomic characterization of Massiliimalia massiliensis gen. nov., sp. nov., and Massiliimalia timonensis gen. nov., sp. nov., two new members of the family Ruminococcaceae isolated from the human gut. Antonie Van Leeuwenhoek. 2019 Jun; 112(6):905-918.
    View in: PubMed
    Score: 0.050
  104. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities. Int J Antimicrob Agents. 2019 Apr; 53(4):355-361.
    View in: PubMed
    Score: 0.050
  105. Mesenteric lymphadenitis as a presenting feature of Whipple's disease: Value of PCR analysis. Int J Infect Dis. 2018 Oct; 75:15-17.
    View in: PubMed
    Score: 0.049
  106. Limbic encephalitis as a relapse of Whipple's disease with digestive involvement and spondylodiscitis. Infection. 2019 Aug; 47(4):637-641.
    View in: PubMed
    Score: 0.049
  107. Eggerthella timonensis sp. nov, a new species isolated from the stool sample of a pygmy female. Microbiologyopen. 2018 10; 7(5):e00575.
    View in: PubMed
    Score: 0.048
  108. Draft Genome and Description of Eisenbergiella massiliensis Strain AT11T: A New Species Isolated from Human Feces After Bariatric Surgery. Curr Microbiol. 2018 Oct; 75(10):1274-1281.
    View in: PubMed
    Score: 0.048
  109. Genome sequence and description of Clostridium niameyense sp. nov., isolated from a human with marasmus in Nigeria. New Microbes New Infect. 2018 Jul; 24:26-31.
    View in: PubMed
    Score: 0.047
  110. Gorillibacterium timonense sp. nov. and Vitreoscilla massiliensis sp. nov., two new bacterial species isolated from stool specimens of obese Amazonian patients. New Microbes New Infect. 2018 May; 23:48-51.
    View in: PubMed
    Score: 0.047
  111. Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections. Clin Infect Dis. 2018 02 10; 66(5):645-650.
    View in: PubMed
    Score: 0.047
  112. Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients. PLoS One. 2018; 13(1):e0191913.
    View in: PubMed
    Score: 0.047
  113. Escherichia coli spontaneous community-acquired meningitis in adults: A case report and literature review. Int J Infect Dis. 2018 Feb; 67:70-74.
    View in: PubMed
    Score: 0.047
  114. Microbial Culturomics Application for Global Health: Noncontiguous Finished Genome Sequence and Description of Pseudomonas massiliensis Strain CB-1T sp. nov. in Brazil. OMICS. 2018 02; 22(2):164-175.
    View in: PubMed
    Score: 0.045
  115. Fluorescence In Situ Hybridization for Diagnosis of Whipple's Disease in Formalin-Fixed Paraffin-Embedded Tissue. Front Med (Lausanne). 2017; 4:87.
    View in: PubMed
    Score: 0.045
  116. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France. Eur J Clin Microbiol Infect Dis. 2017 Oct; 36(10):1971-1974.
    View in: PubMed
    Score: 0.045
  117. Dakarella massiliensis gen. nov., sp. nov., strain ND3T: a new bacterial genus isolated from the female genital tract. New Microbes New Infect. 2017 Jul; 18:38-46.
    View in: PubMed
    Score: 0.045
  118. Genome sequence and description of Anaeromassilibacillus senegalensis gen. nov., sp. nov., isolated from the gut of patient with kwashiorkor. New Microbes New Infect. 2017 May; 17:54-64.
    View in: PubMed
    Score: 0.044
  119. Noncontiguous finished genome sequence and description of Streptococcus timonensis sp. nov. isolated from the human stomach. New Microbes New Infect. 2017 Jan; 15:77-88.
    View in: PubMed
    Score: 0.043
  120. Rubeoparvulum massiliense gen. nov., sp. nov., a new bacterial genus isolated from the human gut of a Senegalese infant with severe acute malnutrition. New Microbes New Infect. 2017 Jan; 15:49-60.
    View in: PubMed
    Score: 0.043
  121. Noncontiguous finished genome sequence and description of Enterococcus massiliensis sp. nov. New Microbes New Infect. 2016 Jul; 12:90-5.
    View in: PubMed
    Score: 0.042
  122. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30.
    View in: PubMed
    Score: 0.036
  123. Non-contiguous finished genome sequence and description of Brevibacillus massiliensis sp. nov. Stand Genomic Sci. 2013 Apr 15; 8(1):1-14.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.